Navigating the Molecular Maze of Alzheimer’s Disease: Developing A Human Hippocampal Atlas to Bridge Discovery and Clinical Practice
Abstract Alzheimer’s disease (AD), the primary cause of dementia worldwide, persists as an enigma, with the specific molecular and cellular mechanisms driving cognitive decline still eluding understanding. To aid in unraveling this enigma, we generated a spatial transcriptomic atlas of the human hippocampus with single-cell resolution, leveraging integration of spatial mapping with single-cell transcriptomic profiles from six individuals with or without AD. Utilizing this complex and multi-dimensional data, the atlas pinpoints AD-associated transcriptomic changes with spatial specificity, such as a pronounced elevation of inflammatory responses and energy metabolism in fimbria and CA4, respectively. AD also caused alterations of the cellular composition in hippocampal subregions, even around the amyloid-beta (Aβ) plaques. Finally, our investigation uncovered pathways intricately linked to synthesis and secretion of extracellular vesicles (EVs). Within these altered pathways, we identified several corresponding proteins, including CCK and PMP2, that are readily detectable in human blood, holding promise for aiding AD diagnosis in clinical settings..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 10. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Pan [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.12.06.23299593 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI041797175 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI041797175 | ||
| 003 | DE-627 | ||
| 005 | 20231211091652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231208s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.12.06.23299593 |2 doi | |
| 035 | |a (DE-627)XBI041797175 | ||
| 035 | |a (biorXiv)10.1101/2023.12.06.23299593 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Pan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Navigating the Molecular Maze of Alzheimer’s Disease: Developing A Human Hippocampal Atlas to Bridge Discovery and Clinical Practice |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Alzheimer’s disease (AD), the primary cause of dementia worldwide, persists as an enigma, with the specific molecular and cellular mechanisms driving cognitive decline still eluding understanding. To aid in unraveling this enigma, we generated a spatial transcriptomic atlas of the human hippocampus with single-cell resolution, leveraging integration of spatial mapping with single-cell transcriptomic profiles from six individuals with or without AD. Utilizing this complex and multi-dimensional data, the atlas pinpoints AD-associated transcriptomic changes with spatial specificity, such as a pronounced elevation of inflammatory responses and energy metabolism in fimbria and CA4, respectively. AD also caused alterations of the cellular composition in hippocampal subregions, even around the amyloid-beta (Aβ) plaques. Finally, our investigation uncovered pathways intricately linked to synthesis and secretion of extracellular vesicles (EVs). Within these altered pathways, we identified several corresponding proteins, including CCK and PMP2, that are readily detectable in human blood, holding promise for aiding AD diagnosis in clinical settings. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Wang, Lifang |4 aut | |
| 700 | 1 | |a Tao, Quyuan |4 aut | |
| 700 | 1 | |a Guo, Zhen |4 aut | |
| 700 | 1 | |a Luo, Ting |4 aut | |
| 700 | 1 | |a Xu, Zhi |4 aut | |
| 700 | 1 | |a He, Youzhe |4 aut | |
| 700 | 1 | |a Yu, Jiayi |4 aut | |
| 700 | 1 | |a Liu, Yuyang |4 aut | |
| 700 | 1 | |a Wu, Zihan |4 aut | |
| 700 | 1 | |a Xu, Bin |4 aut | |
| 700 | 1 | |a Jin, Bufan |4 aut | |
| 700 | 1 | |a Yang, Ying |4 aut | |
| 700 | 1 | |a Cheng, Mengnan |4 aut | |
| 700 | 1 | |a Jiang, Yujia |4 aut | |
| 700 | 1 | |a Tian, Chen |4 aut | |
| 700 | 1 | |a Zheng, Huiwen |4 aut | |
| 700 | 1 | |a Fan, Zhongqin |4 aut | |
| 700 | 1 | |a Jiang, Peiran |4 aut | |
| 700 | 1 | |a Gao, Yue |4 aut | |
| 700 | 1 | |a Wu, Juanli |4 aut | |
| 700 | 1 | |a Wang, Shengpeng |4 aut | |
| 700 | 1 | |a Sun, Bing |4 aut | |
| 700 | 1 | |a Wei, Yanrong |4 aut | |
| 700 | 1 | |a Fang, Zheng |4 aut | |
| 700 | 1 | |a Lei, Junjie |4 aut | |
| 700 | 1 | |a Luo, Benyan |4 aut | |
| 700 | 1 | |a Wen, Huiying |4 aut | |
| 700 | 1 | |a Peng, Guoping |4 aut | |
| 700 | 1 | |a Tang, Yuanchun |4 aut | |
| 700 | 1 | |a Su, Xinhui |4 aut | |
| 700 | 1 | |a Pan, Catherine |4 aut | |
| 700 | 1 | |a Zhu, Keqing |4 aut | |
| 700 | 1 | |a Shen, Yi |4 aut | |
| 700 | 1 | |a Liu, Shiping |4 aut | |
| 700 | 1 | |a Bao, Aimin |4 aut | |
| 700 | 1 | |a Yao, Jianhua |4 aut | |
| 700 | 1 | |a Wang, Jian |4 aut | |
| 700 | 1 | |a Xu, Xun |4 aut | |
| 700 | 1 | |a Li, Xiaoming |4 aut | |
| 700 | 1 | |a Liu, Longqi |4 aut | |
| 700 | 1 | |a Duan, Shumin |4 aut | |
| 700 | 1 | |a Han, Lei |4 aut | |
| 700 | 1 | |a Zhang, Jing |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 10. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.12.06.23299593 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 12 | ||